Omeprazol

Hauptinformation

  • Handelsname:
  • Omeprazol Grünwalder MUT 20 mg, magensaftresistente Tabletten
  • Darreichungsform:
  • magensaftresistente Tablette
  • Zusammensetzung:
  • Omeprazol-Magnesium (Ph.Eur.) 20.6mg
  • Verwenden für:
  • Menschen
  • Art der Medizin:
  • allopathic Droge

Dokumenten

  • für die Allgemeinheit:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie das Informationsblatt für die Öffentlichkeit.

  • Information für medizinisches Fachpersonal:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie die Packungsbeilage für medizinisches Fachpersonal.

Lokalisierung

  • Erhältlich in:
  • Omeprazol Grünwalder MUT 20 mg, magensaftresistente Tabletten
    Deutschland
  • Sprache:
  • Deutsch

Weitere Informationen

Status

  • Quelle:
  • BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte
  • Zulassungsnummer:
  • 85108.00.00
  • Letzte Änderung:
  • 11-04-2018

13-4-2018

Acrodose PLus and PL Systems by Haemonetics: Recall - Low pH Readings for Platelets Stored in CLX HP Bag

Acrodose PLus and PL Systems by Haemonetics: Recall - Low pH Readings for Platelets Stored in CLX HP Bag

Platelets with pH lower than 6.2 and a lack of “swirl” may not be viable. Transfusion of these platelets may lead to delayed correction of coagulopathy or low quality prophylactic platelet transfusion.

FDA - U.S. Food and Drug Administration

24-1-2018

Scientific guideline:  Recommendation to marketing authorisation holders, highlighting recent measures in the veterinary field to promote reduction, refinement and replacement (3Rs) measures described in the European Pharmacopoeia - Applicable to veterina

Scientific guideline: Recommendation to marketing authorisation holders, highlighting recent measures in the veterinary field to promote reduction, refinement and replacement (3Rs) measures described in the European Pharmacopoeia - Applicable to veterina

In accordance with the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes (Council of Europe), tests performed in animals must be carried out in such a way as to use the minimum number of animals and to cause the least pain, suffering, distress or lasting harm. The European Pharmacopeia (Ph. Eur.) has, over the years, applied these principles by implementing alternative tests and assays that reduce, refine and replace animal use.

Europe - EFSA - European Food Safety Authority EFSA Journal

24-1-2018

Scientific guideline:  Recommendation to marketing authorisation holders, highlighting recent measures in the veterinary field to promote replacement, reduction, and refinement (3Rs) measures described in the European Pharmacopoeia - Applicable to human v

Scientific guideline: Recommendation to marketing authorisation holders, highlighting recent measures in the veterinary field to promote replacement, reduction, and refinement (3Rs) measures described in the European Pharmacopoeia - Applicable to human v

In accordance with the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes (Council of Europe), tests performed in animals must be carried out in such a way as to use the minimum number of animals and to cause the least pain, suffering, distress or lasting harm. The European Pharmacopeia (Ph.Eur.) has, over the years, applied these principles by implementing alternative tests and assays that replace, reduce and refine animal use.

Europe - EFSA - European Food Safety Authority EFSA Journal

30-10-2017

Statement from Susan Mayne, Ph.D., on proposal to revoke health claim that soy protein reduces risk of heart disease

Statement from Susan Mayne, Ph.D., on proposal to revoke health claim that soy protein reduces risk of heart disease

Statement from Susan Mayne, Ph.D., on proposal to revoke health claim that soy protein reduces risk of heart disease

FDA - U.S. Food and Drug Administration

8-9-2009

Decision on future reimbursement status of medicinal products in ATC group A06 (laxatives) and A02AA04 (magnesium compounds)

Decision on future reimbursement status of medicinal products in ATC group A06 (laxatives) and A02AA04 (magnesium compounds)

On 3 september 2009, the Danish Medicines Agency decided on the future reimbursement status of medicinal products in ATC group A06 (laxatives) and A02AA04 (magnesium compounds).

Danish Medicines Agency

4-5-2009

Consultation on the reimbursement status of medicinal products in ATC group A06 (laxatives) and A02AA04 (magnesium hydroxide)

Consultation on the reimbursement status of medicinal products in ATC group A06 (laxatives) and A02AA04 (magnesium hydroxide)

At the Danish Medicines Agency's request, the Reimbursement Committee has reassessed the reimbursement status of medicinal products authorised for marketing in Denmark in ATC group A06 (laxatives) and A02AA04 (magnesium hydroxide)

Danish Medicines Agency

6-2-2018

Magnesium Sulfate

Magnesium Sulfate

Magnesium sulfate is a naturally occurring mineral used to control low blood levels of magnesium. Magnesium sulfate injection is also used for pediatric acute nephritis and to prevent seizures in severe pre-eclampsia, eclampsia, or toxemia of pregnancy.

US - RxList

1-2-2018

01.02.2018: Glivec 100 mg, Filmtabletten (teilbar), 60 Tablette(n), 1328.40, -23.3%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer56395002 ZulassungsinhaberNovartis Pharma Schweiz AGNameGlivec 100 mg, Filmtabletten (teilbar)Registrierungsdatum24.09.2003Original/GenerikumOriginalErstzulassung Sequenz24.09.2003ATC-KlassierungImatinib (L01XE01)Revisionsdatum15.09.2004WHOWHO-DDDGültig bis23.09.2018Index Therapeuticus (BSV)07.16.10.Packungsgrösse60 Tablette(n)Index Therapeuticus (Swissmedic)07.16.10.Beschreibung AbgabekategorieA  SL EintragJaAnwendungZytostatikumPh+ chroni...

ODDB -Open Drug Database

1-2-2018

01.02.2018: Glivec 400 mg, Filmtabletten (teilbar), 30 Tablette(n), 2592.85, -23.0%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer56395006 ZulassungsinhaberNovartis Pharma Schweiz AGNameGlivec 400 mg, Filmtabletten (teilbar)Registrierungsdatum24.09.2003Original/GenerikumOriginalErstzulassung Sequenz16.01.2009ATC-KlassierungImatinib (L01XE01)Revisionsdatum15.09.2004WHOWHO-DDDGültig bis23.09.2018Index Therapeuticus (BSV)07.16.10.Packungsgrösse30 Tablette(n)Index Therapeuticus (Swissmedic)07.16.10.Beschreibung AbgabekategorieA  SL EintragJaAnwendungZytostatikumPh+ chroni...

ODDB -Open Drug Database

19-1-2018

MAGNESIUM METALLICUM (Magnesium) Liquid [Washington Homeopathic Products]

MAGNESIUM METALLICUM (Magnesium) Liquid [Washington Homeopathic Products]

Updated Date: Jan 19, 2018 EST

US - DailyMed

1-1-2018

01.01.2018: Sprycel 20 mg, Filmtabletten, 60 Tablette(n), 1952.30, -17.1%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer57658001 PSZulassungsinhaberBristol-Myers Squibb SANameSprycel 20 mg, FilmtablettenRegistrierungsdatum02.02.2007  Erstzulassung Sequenz02.02.2007ATC-KlassierungDasatinib (L01XE06)Revisionsdatum WHOWHO-DDDGültig bis01.02.2022Index Therapeuticus (BSV)07.16.10.Packungsgrösse60 Tablette(n)Index Therapeuticus (Swissmedic)07.16.10.Beschreibung AbgabekategorieA  SL EintragJaAnwendungPhiladelphiachromosom-positive chronische myeloisc...

ODDB -Open Drug Database

1-1-2018

01.01.2018: Sprycel 50 mg, Filmtabletten, 60 Tablette(n), 4159.45, -16.7%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer57658002 PSZulassungsinhaberBristol-Myers Squibb SANameSprycel 50 mg, FilmtablettenRegistrierungsdatum02.02.2007  Erstzulassung Sequenz02.02.2007ATC-KlassierungDasatinib (L01XE06)Revisionsdatum WHOWHO-DDDGültig bis01.02.2022Index Therapeuticus (BSV)07.16.10.Packungsgrösse60 Tablette(n)Index Therapeuticus (Swissmedic)07.16.10.Beschreibung AbgabekategorieA  SL EintragJaAnwendungPhiladelphiachromosom-positive chronische myeloisc...

ODDB -Open Drug Database

1-1-2018

01.01.2018: Sprycel 70 mg, Filmtabletten, 60 Tablette(n), 4159.45, -16.7%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer57658003 PSZulassungsinhaberBristol-Myers Squibb SANameSprycel 70 mg, FilmtablettenRegistrierungsdatum02.02.2007  Erstzulassung Sequenz02.02.2007ATC-KlassierungDasatinib (L01XE06)Revisionsdatum WHOWHO-DDDGültig bis01.02.2022Index Therapeuticus (BSV)07.16.10.Packungsgrösse60 Tablette(n)Index Therapeuticus (Swissmedic)07.16.10.Beschreibung AbgabekategorieA  SL EintragJaAnwendungPhiladelphiachromosom-positive chronische myeloisc...

ODDB -Open Drug Database

1-1-2018

01.01.2018: Sprycel 100 mg, Filmtabletten, 30 Tablette(n), 4268.05, -16.7%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer57658010 PSZulassungsinhaberBristol-Myers Squibb SANameSprycel 100 mg, FilmtablettenRegistrierungsdatum02.02.2007  Erstzulassung Sequenz04.12.2009ATC-KlassierungDasatinib (L01XE06)Revisionsdatum WHOWHO-DDDGültig bis01.02.2022Index Therapeuticus (BSV)07.16.10.Packungsgrösse30 Tablette(n)Index Therapeuticus (Swissmedic)07.16.10.Beschreibung AbgabekategorieA  SL EintragJaAnwendungPhiladelphiachromosom-positive chronische myelois...

ODDB -Open Drug Database

26-12-2017

OMEPRAZOLE MAGNESIUM Capsule [Bi-Mart]

OMEPRAZOLE MAGNESIUM Capsule [Bi-Mart]

Updated Date: Dec 26, 2017 EST

US - DailyMed

11-12-2017

OMEPRAZOLE MAGNESIUM Capsule, Delayed Release [Albertsons Companies]

OMEPRAZOLE MAGNESIUM Capsule, Delayed Release [Albertsons Companies]

Updated Date: Dec 11, 2017 EST

US - DailyMed

8-12-2017

OMEPRAZOLE MAGNESIUM Capsule, Delayed Release [Meijer Distribution Inc]

OMEPRAZOLE MAGNESIUM Capsule, Delayed Release [Meijer Distribution Inc]

Updated Date: Dec 8, 2017 EST

US - DailyMed

8-12-2017

OMEPRAZOLE MAGNESIUM Capsule, Delayed Release [CVS Health Corp.]

OMEPRAZOLE MAGNESIUM Capsule, Delayed Release [CVS Health Corp.]

Updated Date: Dec 8, 2017 EST

US - DailyMed

8-12-2017

OMEPRAZOLE MAGNESIUM Capsule, Delayed Release [HEB]

OMEPRAZOLE MAGNESIUM Capsule, Delayed Release [HEB]

Updated Date: Dec 8, 2017 EST

US - DailyMed

8-12-2017

OMEPRAZOLE MAGNESIUM Capsule, Delayed Release [Kaiser Permanente]

OMEPRAZOLE MAGNESIUM Capsule, Delayed Release [Kaiser Permanente]

Updated Date: Dec 8, 2017 EST

US - DailyMed

6-12-2017

OMEPRAZOLE MAGNESIUM Capsule, Delayed Release [Chain Drug Marketing Association]

OMEPRAZOLE MAGNESIUM Capsule, Delayed Release [Chain Drug Marketing Association]

Updated Date: Dec 6, 2017 EST

US - DailyMed

27-11-2017

EPSOM SALT MAGNESIUM SULFATE (Magnesium Sulfate) Granule [TARGET Corporation]

EPSOM SALT MAGNESIUM SULFATE (Magnesium Sulfate) Granule [TARGET Corporation]

Updated Date: Nov 27, 2017 EST

US - DailyMed

25-8-2017

PRILOSEC (Omeprazole Magnesium) Granule, Delayed Release [Covis Pharma]

PRILOSEC (Omeprazole Magnesium) Granule, Delayed Release [Covis Pharma]

Updated Date: Aug 25, 2017 EST

US - DailyMed

17-8-2017

HEPAR MAGNESIUM TARAXICUM 4 (Hepar Magnesium 4) Liquid [Uriel Pharmacy Inc.]

HEPAR MAGNESIUM TARAXICUM 4 (Hepar Magnesium 4) Liquid [Uriel Pharmacy Inc.]

Updated Date: Aug 17, 2017 EST

US - DailyMed

9-8-2017

OMEPRAZOLE MAGNESIUM Capsule, Delayed Release [Dr. Reddy'S Laboratories Limited]

OMEPRAZOLE MAGNESIUM Capsule, Delayed Release [Dr. Reddy'S Laboratories Limited]

Updated Date: Aug 9, 2017 EST

US - DailyMed

27-7-2017

Magnesium Oxide

Magnesium Oxide

Magnesium oxide is an over-the-counter mineral effective as treatment for many diseases and disorders

US - RxList

14-6-2017

OMEPRAZOLE MAGNESIUM Capsule, Delayed Release [Gericare Pharmaceuticals]

OMEPRAZOLE MAGNESIUM Capsule, Delayed Release [Gericare Pharmaceuticals]

Updated Date: Jun 14, 2017 EST

US - DailyMed

13-6-2017

Magnesium Citrate

Magnesium Citrate

Magnesium citrate is an over-the-counter (OTC) medication that can be used as a nutritional supplement or for treatment of acid indigestion and constipation. Learn about side effects, drug interactions, dosages, warnings, and more.

US - RxList

13-6-2017

Magnesium Chloride

Magnesium Chloride

Magnesium is a mineral that is important for normal bone structure in the body. People get magnesium from their diet, but sometimes magnesium supplements are needed if magnesium levels are too low. Learn about side effects, drug interactions, dosages, warnings, and more.

US - RxList

7-6-2017

MAGNESIUM METALLICUM (Magnesium) Pellet [Washington Homeopathic Products]

MAGNESIUM METALLICUM (Magnesium) Pellet [Washington Homeopathic Products]

Updated Date: Jun 7, 2017 EST

US - DailyMed

22-5-2017

EPSOM SALT MAGNESIUM SULFATE (Magnesium Sulfate) Granule [CVS Pharmacy]

EPSOM SALT MAGNESIUM SULFATE (Magnesium Sulfate) Granule [CVS Pharmacy]

Updated Date: May 22, 2017 EST

US - DailyMed